- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Fruitura Bioscience Ltd.
Total 371 results
-
Clexio Biosciences Ltd.CompletedAdjunctive Treatment of Major Depressive DisorderUnited States, Puerto Rico
-
Liminal BioSciences Ltd.Completed
-
Liminal BioSciences Ltd.Terminated
-
Chipscreen Biosciences, Ltd.CompletedType 2 DiabetesChina
-
Chipscreen Biosciences, Ltd.Terminated
-
Prothena Biosciences Ltd.TerminatedAL AmyloidosisUnited States
-
Prothena Biosciences Ltd.CompletedAL AmyloidosisUnited States, Spain, Australia, Germany, United Kingdom, France, Greece, Israel, Italy, Austria
-
Clexio Biosciences Ltd.RecruitingChronic Pruritus in Adult Subjects With Notalgia Paresthetica (NP)United States
-
Chipscreen Biosciences, Ltd.Recruiting
-
Chipscreen Biosciences, Ltd.Not yet recruiting
-
Modern Biosciences LtdRecruitingIdiopathic Pulmonary FibrosisUnited States, United Kingdom, Israel, France, Germany, Greece, Hungary, Italy, Spain
-
Chimagen Biosciences, LtdRecruitingNon-Hodgkin's Lymphoma (Disorder) | Acute Lymphoid Leukemia, Disease (Disorder)United States
-
Chipscreen Biosciences, Ltd.RecruitingSmall Cell Lung Cancer | Advanced Solid Malignant TumorUnited States
-
Chipscreen Biosciences, Ltd.Recruiting
-
Chipscreen Biosciences, Ltd.RecruitingOvarian Cancer | Relapsed or Refractory | Chiauranib | PaclitaxelChina
-
Chipscreen Biosciences, Ltd.RecruitingSmall Cell Lung CancerChina
-
Prothena Biosciences Ltd.TerminatedPrimary Systemic (AL) AmyloidosisUnited States, Spain, Israel, Canada, Poland, Netherlands, France, Germany, United Kingdom, Belgium, Denmark, Greece, Australia, Austria, Italy
-
Chipscreen Biosciences, Ltd.Completed
-
Leadiant Biosciences Ltd.CompletedCerebrotendinous Xanthomatoses
-
Chipscreen Biosciences, Ltd.CompletedChiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's LymphomaNon-hodgkin's LymphomaChina
-
Chipscreen Biosciences, Ltd.CompletedHepatocellular CarcinomaChina
-
Liminal BioSciences Ltd.TerminatedAlström SyndromeUnited Kingdom
-
Chipscreen Biosciences, Ltd.Completed
-
Modern Biosciences LtdCompletedRheumatoid ArthritisGeorgia, Moldova, Republic of, Romania
-
Liminal BioSciences Ltd.CompletedDiabetes | Inflammation and FibrosisUnited Kingdom
-
Prothena Biosciences Ltd.CompletedPrimary AmyloidosisUnited States
-
Liminal BioSciences Ltd.CompletedMetabolic Syndrome | Type 2 DiabetesCanada
-
PeriTec Biosciences Ltd.UnknownVascular Disease, PeripheralChile
-
Norroy Bioscience Co., LTDRecruiting
-
Ikaria Bioscience Pty LtdRecruitingTo Reduce the LDL-C Level in Hypercholesteremia Adult Patients | Combination for Subgroup High LDL-c Patients With Other ComorbiditiesAustralia
-
Norroy Bioscience Co., LTDRecruitingClear Cell Renal Cell Carcinoma MetastaticChina
-
SK Bioscience Co., Ltd.CompletedInfluenzaKorea, Republic of
-
Zomagen Biosciences, LtdCompletedCryopyrin Associated Periodic SyndromeUnited States
-
Akaza Bioscience LtdIqvia Pty LtdNot yet recruitingAcute-On-Chronic Liver Failure
-
Futura Medical Developments Ltd.Richmond Pharmacology LimitedCompletedErectile DysfunctionUnited Kingdom
-
Liminal BioSciences Ltd.CelerionCompletedHealthyUnited States
-
Sciwind Biosciences APAC CO Pty. Ltd.Hangzhou Sciwind Biosciences Co., Ltd.; Sciwind Biosciences USA Co., Ltd.WithdrawnCOVID-19 Acute Respiratory Distress SyndromeArgentina, Peru
-
Dimerix Bioscience Pty LtdIqvia Pty LtdCompletedDiabetic Kidney DiseaseAustralia
-
Mabwell (Shanghai) Bioscience Co., Ltd.Not yet recruitingAdvanced Urothelial CarcinomaChina
-
Shanghai Junshi Bioscience Co., Ltd.Recruiting
-
Mabwell (Shanghai) Bioscience Co., Ltd.RecruitingIdiopathic Pulmonary FibrosisChina
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingAdvanced Nasopharyngeal CarcinomaChina
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingAdvanced Lung CancerChina
-
Mabwell (Shanghai) Bioscience Co., Ltd.Not yet recruiting
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingRelapsed or Metastatic Non-small Cell Lung CancerChina
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingRecurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Who Have Failed at Least Two Prior Lines of TherapyChina
-
Shanghai Junshi Bioscience Co., Ltd.CompletedAdvanced or Metastatic Esophageal Squamous Cell Cancer Without Previous Systemic ChemotherapyChina
-
Shanghai Junshi Bioscience Co., Ltd.CompletedHeterozygous Familial HypercholesterolemiaChina
-
Shanghai Junshi Bioscience Co., Ltd.TerminatedHepatocellular CarcinomaChina
-
Mabwell (Shanghai) Bioscience Co., Ltd.Completed